Stony Brook University — Stony Brook, New York

Public research footprint of Stony Brook University, compiled from the ClinicalTrials.gov public registry.

885

Registered studies

296

Active

136

Recruiting now

421

Completed

104

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Stage IIIB Lung Cancer AJCC v8 · Breast Cancer · Anatomic Stage II Breast Cancer AJCC v8

Recently updated registry entries

NCT05232916 — Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 +… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)
NCT06055920 — The PEERLESS II Study (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Stony Brook University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.